Skip to content

Apogee Therapeutics, Inc. APGE Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$8.23M+98.6%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.89M+272%
Amgen logo
AmgenAMGN
$12.76B+12.0%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%
Total assets$1.3B+81.1%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$6.81B+189%
Enterprise value$6.37B+181%

Returns & leverage

See full
Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Therapeutics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apogee Therapeutics, Inc.'s other non-current assets?
Apogee Therapeutics, Inc. (APGE) reported other non-current assets of $8.52M in Q1 2026.
How has Apogee Therapeutics, Inc.'s other non-current assets changed year-over-year?
Apogee Therapeutics, Inc.'s other non-current assets increased by 16.0% year-over-year, from $7.34M to $8.52M.
What is the long-term trend for Apogee Therapeutics, Inc.'s other non-current assets?
Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s other non-current assets has grown at a 365.0% compound annual growth rate (CAGR), from $401K to $8.67M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.